Comparison of low-dose meglumine antimoniate/ allopurinol combination therapy with full dose meglumine antimoniate alone in the treatment of cutaneous leishmaniasis - A randomized controlled trial

Journal of Pakistan Association of Dermatologists

Volumn 24, Issue 2, 2014, Pages 108-114

  Ejaz, Amer ^a   Qadir, Syed Noor Ur Rasool ^b   Malik, Naveed ^c   Bari, Arfan Ul ^a  

^a Malir National University of Medical Sciences   (Pakistan)

^b PAF Base Hospital   (Pakistan)

^c PNS SHIFA HOSPITAL   (Pakistan)

Author keywords

Allopurinol; Cutaneous leishmaniasis; Meglumine antimoniate; Randomized controlled trial

Indexed keywords

ALLOPURINOL; MEGLUMINE ANTIMONATE;

ABSCESS; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEALING; HUMAN; INJECTION PAIN; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; RANDOMIZED CONTROLLED TRIAL; SECONDARY INFECTION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN INDURATION; SKIN LEISHMANIASIS; SYSTEMIC THERAPY; THORAX PAIN; ULCER; URTICARIA; VOMITING;

EID: 84906096491     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of old world cutaneous leishmaniasis. Int J Dermatol. 2007;46:132-42.
2. Davies CR, Kaye P, Croft SL. Leishmaniasis: new approaches to disease control. BMJ. 2003;326:377-82.
3. Valencia C, Arévalo J, Dujardin JC et al. Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS Negl Trop Dis. 2012;6:e1656.
4. Wise E, Armstrong M, Watson J, Lockwood D. Monitoring toxicity associated with parenteral sodium stibogluconate in the day case management of returned travelers with new world cutaneous leishmaniasis. PLoS Negl Trop Dis. 2012;6:e1688.
5. Oliveira-Neto M, Mattos M. Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony. Revista da Socieda de Brasileira de Medicina Tropical. 2006;39:376-8.
6. Oliveira-Neto MP, Schubach A, Mattos M et al. A low dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow up studies (up to 10 years). Am J Trop Med Hyg. 1997;57:651-5.
7. Walton BC, Harper J 3rd, Neal RA. Effectiveness of allopurinol against leishmania Braziliensis Panamensis in Autos trivirgatus. Am J Trop Med Hyg. 1983;32:46-50.
8. Baum KF, Berens RL. Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole. Clin Infect Dis. 1994;18:813-5.
9. Martinez S, Gonzalez M, Vernaza ME. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis. 1997;24:165-9.
10. Momeni AZ, Reiszadae MR, Aminjavaheri M. Treatment of cutaneous leishmaniasis with a combination of allopurinol and lowdose meglumine antimoniate. Int J Dermatol. 2002;41:441-3.
11. Whitley E, Ball J. Statistics review 4: Sample size calculations. Crit Care. 2002;6:335-41.
12. Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2002;41:521-4.
13. Momeni AZ, Aminjavaheri M. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol. Eur J Dermatol. 2003;13:40-3.
14. Velez I, Agudelo S, Hendrickx E et al. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med. 1997;126:232-6.
15. Ramesh V, Kumar J, Kumar D, Salotra P.A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol. 2010;76:138- 44.
16. Esfandiarpour I, Dabiri SH. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. Int J Dermatol. 2007;46:848-52.